Susquehanna International Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $203M | Buy |
3,235,100
+1,924,100
| +147% | +$154M | 0.02% | 517 |
|
|
2025
Q4 | $125M | Sell |
1,311,000
-795,500
| -38% | -$78M | 0.01% | 747 |
|
|
2025
Q3 | $206M | Buy |
2,106,500
+46,800
| +2% | +$4.85M | 0.02% | 528 |
|
|
2025
Q2 | $221M | Sell |
2,059,700
-250,400
| -11% | -$25.3M | 0.03% | 428 |
|
|
2025
Q1 | $233M | Sell |
2,310,100
-549,100
| -19% | -$55.3M | 0.04% | 345 |
|
|
2024
Q4 | $255M | Buy |
2,859,200
+1,924,100
| +206% | +$169M | 0.04% | 351 |
|
|
2024
Q3 | $78.4M | Buy |
935,100
+113,000
| +14% | +$8.91M | 0.01% | 791 |
|
|
2024
Q2 | $63.3M | Sell |
822,100
-290,100
| -26% | -$21.2M | 0.01% | 835 |
|
|
2024
Q1 | $76.2M | Sell |
1,112,200
-531,000
| -32% | -$34.1M | 0.01% | 795 |
|
|
2023
Q4 | $95M | Sell |
1,643,200
-941,600
| -36% | -$50.3M | 0.02% | 699 |
|
|
2023
Q3 | $136M | Buy |
2,584,800
+1,743,200
| +207% | +$91.4M | 0.03% | 484 |
|
|
2023
Q2 | $45.5M | Buy |
841,600
+520,700
| +162% | +$27.2M | 0.01% | 1063 |
|
|
2023
Q1 | $16.1M | Sell |
320,900
-440,900
| -58% | -$20.8M | ﹤0.01% | 1919 |
|
|
2022
Q4 | $35.2M | Sell |
761,800
-256,400
| -25% | -$11.1M | 0.01% | 1088 |
|
|
2022
Q3 | $39.4M | Sell |
1,018,200
-86,700
| -8% | -$3.48M | 0.01% | 944 |
|
|
2022
Q2 | $41.2M | Buy |
1,104,900
+98,000
| +10% | +$3.99M | 0.01% | 954 |
|
|
2022
Q1 | $44.6M | Sell |
1,006,900
-366,800
| -27% | -$15.9M | 0.01% | 1066 |
|
|
2021
Q4 | $58.4M | Sell |
1,373,700
-567,700
| -29% | -$23.9M | 0.01% | 998 |
|
|
2021
Q3 | $84.2M | Buy |
1,941,400
+439,800
| +29% | +$19.5M | 0.01% | 867 |
|
|
2021
Q2 | $64.2M | Buy |
1,501,600
+303,700
| +25% | +$12.8M | 0.01% | 1027 |
|
|
2021
Q1 | $46.3M | Buy |
1,197,900
+572,600
| +92% | +$21.7M | 0.01% | 1163 |
|
|
2020
Q4 | $22.5M | Buy |
625,300
+77,500
| +14% | +$2.79M | ﹤0.01% | 1611 |
|
|
2020
Q3 | $20.9M | Sell |
547,800
-262,400
| -32% | -$10.1M | ﹤0.01% | 1440 |
|
|
2020
Q2 | $28.4M | Sell |
810,200
-260,000
| -24% | -$9.36M | 0.01% | 1168 |
|
|
2020
Q1 | $34.9M | Buy |
1,070,200
+116,500
| +12% | +$4.55M | 0.01% | 841 |
|
|
2019
Q4 | $43.1M | Buy |
953,700
+413,100
| +76% | +$17.3M | 0.01% | 905 |
|
|
2019
Q3 | $22M | Sell |
540,600
-683,100
| -56% | -$28.9M | 0.01% | 1268 |
|
|
2019
Q2 | $52.6M | Buy |
1,223,700
+855,400
| +232% | +$32.9M | 0.02% | 665 |
|
|
2019
Q1 | $14.1M | Sell |
368,300
-150,700
| -29% | -$5.76M | 0.01% | 1457 |
|
|
2018
Q4 | $18.3M | Sell |
519,000
-70,800
| -12% | -$2.57M | 0.01% | 1135 |
|
|
2018
Q3 | $22.7M | Sell |
589,800
-693,700
| -54% | -$24.2M | 0.01% | 1227 |
|
|
2018
Q2 | $42M | Buy |
1,283,500
+837,500
| +188% | +$25.3M | 0.01% | 777 |
|
|
2018
Q1 | $12.2M | Sell |
446,000
-12,200
| -3% | -$332K | ﹤0.01% | 1610 |
|
|
2017
Q4 | $11.4M | Buy |
458,200
+286,900
| +167% | +$7.91M | ﹤0.01% | 1721 |
|
|
2017
Q3 | $5M | Sell |
171,300
-103,000
| -38% | -$2.84M | ﹤0.01% | 2498 |
|
|
2017
Q2 | $7.6M | Buy |
274,300
+22,600
| +9% | +$600K | ﹤0.01% | 1934 |
|
|
2017
Q1 | $6.26M | Sell |
251,700
-72,600
| -22% | -$1.77M | ﹤0.01% | 2113 |
|
|
2016
Q4 | $7.01M | Sell |
324,300
-33,200
| -9% | -$724K | ﹤0.01% | 1948 |
|
|
2016
Q3 | $8.51M | Buy |
357,500
+39,200
| +12% | +$935K | ﹤0.01% | 1643 |
|
|
2016
Q2 | $7.44M | Sell |
318,300
-163,600
| -34% | -$3.54M | ﹤0.01% | 1725 |
|
|
2016
Q1 | $9.06M | Buy |
481,900
+84,200
| +21% | +$1.48M | ﹤0.01% | 1654 |
|
|
2015
Q4 | $7.33M | Buy |
397,700
+212,400
| +115% | +$3.81M | ﹤0.01% | 2077 |
|
|
2015
Q3 | $3.04M | Sell |
185,300
-103,100
| -36% | -$1.76M | ﹤0.01% | 3473 |
|
|
2015
Q2 | $5.11M | Sell |
288,400
-200,900
| -41% | -$3.59M | ﹤0.01% | 2880 |
|
|
2015
Q1 | $8.69M | Sell |
489,300
-229,700
| -32% | -$3.63M | ﹤0.01% | 2016 |
|
|
2014
Q4 | $9.53M | Buy |
719,000
+514,300
| +251% | +$6.57M | ﹤0.01% | 2089 |
|
|
2014
Q3 | $2.42M | Sell |
204,700
-336,900
| -62% | -$4.24M | ﹤0.01% | 4272 |
|
|
2014
Q2 | $6.92M | Buy |
541,600
+25,100
| +5% | +$326K | ﹤0.01% | 2590 |
|
|
2014
Q1 | $6.98M | Buy |
516,500
+242,200
| +88% | +$3.18M | ﹤0.01% | 2444 |
|
|
2013
Q4 | $3.3M | Sell |
274,300
-5,500
| -2% | -$65K | ﹤0.01% | 3523 |
|
|
2013
Q3 | $3.29M | Buy |
279,800
+39,900
| +17% | +$432K | ﹤0.01% | 3339 |
|
|
2013
Q2 | $2.22M | Buy |
+239,900
| New | +$2.03M | ﹤0.01% | 3745 |
|
Other funds holding BSX
VCM
VPM
Susquehanna International Group's BSX Position: Q1 2026 in Review
Susquehanna International Group increased its Boston Scientific (BSX) stake by 86% in Q1 2026, buying an estimated $38.2M and bringing the position to 1,033,109 shares worth $64.8M. The position accounts for 0.01% of the portfolio, ranked #1095.
Susquehanna International Group first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. The position peaked at $75.4M in Q1 2023. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Susquehanna International Group held 1,033,109 shares of Boston Scientific worth $64.8M as of Q1 2026.
- Susquehanna International Group bought 477,139 Boston Scientific shares in Q1 2026, an estimated $38.2M.
- Boston Scientific made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1095 holding.
- Susquehanna International Group first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's Boston Scientific position peaked at $75.4M in Q1 2023.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.